参考文献/References:
[1]刘岩,任思思,马秋晟,等.血清 miR-10a、IL-35 水平对脓毒症并发急性肾损伤的诊断效能[J].山东医药,2020,60(9):44-47.[2]霍锐,戴敏,樊艺,等.miRNA-29a和miRNA-10a-5p对脓毒症所致急性肾损伤患者28d死亡率的预测价值[J].南方医科大学学报,2017,37(5):646-651.[3]Xia S,Lin H,Liu H,et al.Honokiol attenuates sepsis-associated acute kidney injury via the inhibition of oxidative stress and inflammation[J].Inflammation,2019,42(3):826-834.[4]Gameiro J,Fonseca JA,Jorge S,et al.Neutrophil, lymphocyte and platelet ratio as a predictor of mortality in septic-acute kidney injury patients[J].Nefrologia (Engl Ed),2020,40(4):461-468.[5]陈晓洁,董天皞,张桂萍,等.脓毒症定义和诊断标准的演进[J].医学综述,2017,23(16):3230-3235.[6]李世军,刘志红.改善全球肾脏病预后组织(KDI-GO)临床实践指南:肾小球肾炎[J].肾脏病与透析肾移植杂志,2012,21(3):260-267.[7]Prowle JR,Bellomo R.Sepsis-associated acute kidney injury: macrohemodynamic and microhemodynamic alterations in the renal circulation[J].Semin Nephrol,2015,35(1):64-74.[8]Gameiro J,Fonseca JA,Dias JM,et al.Neutrophil, lymphocyte and platelet ratio as a predictor of postoperative acute kidney injury in major abdominal surgery[J].BMC Nephrol,2018,19(1):320.[9]Dewitte A,Lepreux S,Villeneuve J,et al.Blood platelets and sepsis pathophysiology: A new therapeutic prospect in critically [corrected] ill patients?[J].Ann Intensive Care,2017,7(1):115.[10]张小彬,刘丹,闫晶,等.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值评估脓毒症患者预后的价值[J].宁夏医科大学学报,2020,42(4):367-371.[11]崔久庆,刘秀娟,滑立伟,等.中性粒细胞/淋巴细胞比值对脓毒性休克患者预后的评估价值[J].医学理论与实践,2018,31(9):1267-1270. [12]Luo M,Yang Y,Xu J,et al.A new scoring model for the prediction of mortality in patients with acute kidney injury[J].Sci Rep,2017,7(1):7862.[13]温莉玲,陈家佳,梁红丽.尿NGAL、KIM-1联合APACHEⅡ评分对脓毒症急性肾损伤诊断及预后的价值[J].临床急诊杂志,2019,20(2):110-114.
相似文献/References:
[1]何晓芳,罗会芹,闫 滢,等.胃癌术后外周血单核细胞、淋巴细胞水平变化对胃癌肝转移患者预后的影响[J].医学信息,2020,33(06):66.[doi:10.3969/j.issn.1006-1959.2020.06.020]
HE Xiao-fang,LUO Hui-qin,YAN Ying,et al.Effects of Changes in Peripheral Blood Mononuclear Cells and Lymphocytes on Gastric Cancer Patients with Liver Metastasis After Operation[J].Medical Information,2020,33(19):66.[doi:10.3969/j.issn.1006-1959.2020.06.020]
[2]刘婕妤,方智辉,李文克,等.伊布替尼与氟达拉滨联合环磷酰胺治疗慢性淋巴细胞白血病的疗效[J].医学信息,2020,33(13):148.[doi:10.3969/j.issn.1006-1959.2020.13.044]
LIU Jie-yu,FANG Zhi-hui,LI Wen-ke,et al.Efficacy of Ibrutinib and Fludarabine Combined with Cyclophosphamide in the Treatment of Chronic Lymphocytic Leukemia[J].Medical Information,2020,33(19):148.[doi:10.3969/j.issn.1006-1959.2020.13.044]
[3]勾 熙,叶玉伟,刘 敏,等.血小板与淋巴细胞比值在溃疡性结肠炎患者病情评估中的价值[J].医学信息,2021,34(08):168.[doi:10.3969/j.issn.1006-1959.2021.08.046]
GOU Xi,YE Yu-wei,LIU Min,et al.The Value of the Ratio of Platelets to Lymphocytes in the Evaluation of Patients with Ulcerative Colitis[J].Medical Information,2021,34(19):168.[doi:10.3969/j.issn.1006-1959.2021.08.046]
[4]陆 皓,陈海琳,鲍计章,等.免疫抑制性细胞在免疫性血小板减少症中的作用[J].医学信息,2021,34(13):23.[doi:10.3969/j.issn.1006-1959.2021.13.007]
LU Hao,CHEN Hai-lin,BAO Ji-zhang,et al.The Role of Immunosuppressive Cells in Immune Thrombocytopenia[J].Medical Information,2021,34(19):23.[doi:10.3969/j.issn.1006-1959.2021.13.007]
[5]徐晓雪.CD4单阳参考品辅助检测九色标记人血样品的流式分析技术[J].医学信息,2021,34(20):90.[doi:10.3969/j.issn.1006-1959.2021.20.022]
XU Xiao-xue.Flow Pattern Analysis Technique for CD4 Single-positive Reference Substance-assisted Detection of Nine-color Labeled Human Blood Samples[J].Medical Information,2021,34(19):90.[doi:10.3969/j.issn.1006-1959.2021.20.022]
[6]任默涵,于东海,吴 迪.MTHFD2基因在膀胱癌中的表达、功能富集及信号通路的生物信息学分析[J].医学信息,2022,35(24):18.[doi:10.3969/j.issn.1006-1959.2022.24.004]
REN Mo-han,YU Dong-hai,WU Di.Expression, Functional Enrichment and Bioinformatics Analysis of MTHFD2 Gene in Bladder Cancer[J].Medical Information,2022,35(19):18.[doi:10.3969/j.issn.1006-1959.2022.24.004]
[7]唐小莉,方长太,陈园园.CD4+T细胞百分比、淋巴细胞对老年脓毒症继发慢重症的临床应用价值[J].医学信息,2023,36(12):102.[doi:10.3969/j.issn.1006-1959.2023.12.019]
TANG Xiao-li,FANG Chang-tai,CHEN Yuan-yuan.The Clinical Application Value of the Percentage of CD4+T Cell and Lymphocyte in Elderly Patients with Chronic Critical Illness After Sepsis[J].Medical Information,2023,36(19):102.[doi:10.3969/j.issn.1006-1959.2023.12.019]
[8]焦 燕,夏海龙,张舒颖.全身炎症反应指数对多发性骨髓瘤患者疗效及预后的评估价值[J].医学信息,2024,37(05):96.[doi:10.3969/j.issn.1006-1959.2024.05.016]
JIAO Yan,XIA Hai-long,ZHANG Shu-ying.Value of Systemic Inflammation Response Index for the Efficacy and Prognostic Evaluation of Multiple Myeloma Patients[J].Medical Information,2024,37(19):96.[doi:10.3969/j.issn.1006-1959.2024.05.016]
[9]马晓云.中性粒细胞/淋巴细胞水平与2型糖尿病及其动脉粥样硬化的研究[J].医学信息,2021,34(18):47.[doi:10.3969/j.issn.1006-1959.2021.18.012]
MA Xiao-yun.Neutrophil/Lymphocyte Level and Type 2 Diabetes and its Atherosclerosis[J].Medical Information,2021,34(19):47.[doi:10.3969/j.issn.1006-1959.2021.18.012]
[10]贾鹏飞,崔海燕,胡宝荣.中性粒细胞与淋巴细胞和血小板乘积的比值对重症肺炎患者短期生存状态的预测价值[J].医学信息,2022,35(15):79.[doi:10.3969/j.issn.1006-1959.2022.15.017]
JIA Peng-fei,CUI Hai-yan,HU Bao-rong.The Predictive Value of Neutrophil to Lymphocyte and Platelet Ratio for Short-term Survival in Patients with Severe Pneumonia[J].Medical Information,2022,35(19):79.[doi:10.3969/j.issn.1006-1959.2022.15.017]